Thrivent Financial for Lutherans’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Sell |
45,130
-2,769
| -6% | -$190K | 0.01% | 1068 |
|
|
2025
Q1 | $5.21M | Sell |
47,899
-72,736
| -60% | -$7.91M | 0.01% | 819 |
|
|
2024
Q4 | $11.5M | Sell |
120,635
-8,965
| -7% | -$852K | 0.02% | 613 |
|
|
2024
Q3 | $15.4M | Sell |
129,600
-660,825
| -84% | -$78.7M | 0.03% | 540 |
|
|
2024
Q2 | $113M | Sell |
790,425
-545,344
| -41% | -$77.8M | 0.23% | 101 |
|
|
2024
Q1 | $172M | Sell |
1,335,769
-67,624
| -5% | -$8.68M | 0.34% | 53 |
|
|
2023
Q4 | $145M | Buy |
1,403,393
+359,798
| +34% | +$37.2M | 0.32% | 64 |
|
|
2023
Q3 | $94.9M | Buy |
1,043,595
+451,797
| +76% | +$41.1M | 0.23% | 123 |
|
|
2023
Q2 | $47.9M | Buy |
591,798
+15,458
| +3% | +$1.25M | 0.11% | 242 |
|
|
2023
Q1 | $45.9M | Sell |
576,340
-461,290
| -44% | -$36.7M | 0.11% | 238 |
|
|
2022
Q4 | $70.2M | Sell |
1,037,630
-507,742
| -33% | -$34.4M | 0.18% | 156 |
|
|
2022
Q3 | $77M | Buy |
1,545,372
+133,572
| +9% | +$6.65M | 0.21% | 125 |
|
|
2022
Q2 | $78.7M | Sell |
1,411,800
-291,392
| -17% | -$16.2M | 0.21% | 120 |
|
|
2022
Q1 | $94.6M | Buy |
1,703,192
+60,052
| +4% | +$3.33M | 0.19% | 136 |
|
|
2021
Q4 | $92M | Buy |
1,643,140
+299,794
| +22% | +$16.8M | 0.18% | 146 |
|
|
2021
Q3 | $64.5M | Sell |
1,343,346
-454,168
| -25% | -$21.8M | 0.13% | 193 |
|
|
2021
Q2 | $75.3M | Buy |
1,797,514
+78,076
| +5% | +$3.27M | 0.15% | 168 |
|
|
2021
Q1 | $58M | Buy |
1,719,438
+133,402
| +8% | +$4.5M | 0.13% | 200 |
|
|
2020
Q4 | $55.4M | Buy |
1,586,036
+122,136
| +8% | +$4.27M | 0.13% | 198 |
|
|
2020
Q3 | $50.8M | Buy |
1,463,900
+12,812
| +0.9% | +$445K | 0.14% | 184 |
|
|
2020
Q2 | $47.5M | Buy |
+1,451,088
| New | +$47.5M | 0.14% | 175 |
|
|
2013
Q3 | – | Sell |
-13,000
| Closed | -$201 | – | 1584 |
|
|
2013
Q2 | $201 | Buy |
+13,000
| New | +$201 | ﹤0.01% | 1438 |
|